Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Realief Neuropathy Centers

Realief Neuropathy Centers
2010 FOUNDED
PRIVATE STATUS
1-10 EMPLOYEES
Early Stage VC LATEST DEAL TYPE
$1.32M LATEST DEAL AMOUNT
1 INVESTORS
Description

Developer of therapeutic treatment designed to address the issue of peripheral neuropathy. The company's treatment is a multi-modality non-invasive treatment protocol combining the emerging technology of photo-biomodulation and physiotherapy, enabling physicians and doctors to treat numbness,pain and symptoms of peripheral neuropathy.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Clinics/Outpatient Services
Other Industries
Other Healthcare
Primary Office
  • 7100 Northland Circle North
  • Suite 119
  • Brooklyn Park, MN 55428
  • United States

+1 (763) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Realief Neuropathy Centers’s full profile, request a free trial.

Realief Neuropathy Centers Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Early Stage VC 01-Aug-2013 $1.32M 00.000 Completed Generating Revenue
To view this company’s complete deal history including valuation and funding, request access »

Realief Neuropathy Centers Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Gopher Angels Angel Group Minority 000 0000 000000 0

Realief Neuropathy Centers Executive Team (4)

Name Title Board
Seat
Contact
Info
Philip Walter Chief Executive Officer & Co-Founder
Josh Reed Chief Technology Officer
Robert Weigel Co-Founder & Executive, Business & Development Operations

1 Former Executive

You’re viewing 3 of 4 executives. Get the full list »